Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Flame-protected impact-modified polycarbonate compositions
Circuit device for preventing radiation emission in portable terminal with two cameras
Information processing apparatus and update information obtainment method
Methods and systems for flicker correction
Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria
Biosensor kit
Bundled flexible cable with water resistant structure
  Randomly Featured Patents
Miniature disc drive for notebook computer
Sole construction for energy storage and rebound
Method of identifying agonists and antagonist for CC-CKR5 receptor
Method for altering elliptically polarized light
Avoiding data loss and reducing registration overhead in packet networks
Semiconductor device having group III nitride buffer layer and growth layers
Semiconductor device with improved power supply arrangement
Method for introducing materials into a medium
One-piece pushbutton dispensing cap for pressurized container
Openable and obliquely rotatable umbrella